Healthcare Sector Report October 2017

For updated information, please visit www.ibef.org October 2017
HEALTHCARE

.
Table of Content
Executive Summary……………….……….3
Advantage India…………………..….……..4
Market Overview and Trends………….....6
Porter’s Five Forces Framework………...13
Strategies Adopted………….……...…..…15
Growth Drivers...………………………......17
Opportunities…………….………...........…30
Case Studies……..….………………..……34
Key Industry Organizations..……........…..37
Useful information……….……………..…..39

For updated information, please visit www.ibef.orgHealthcare3
EXECUTIVE SUMMARY
Source: Business Standard, Ministry of External Affairs, Ministry of External Affairs (Investment and Technology Promotion Division)
 India is expected to rank amongst the top 3 healthcare markets in terms of incremental growth by 2020
 In 2015, Indian healthcare sector became the 5th largest employer, both in terms of direct as well as indirect
employment, with total direct employment of 4,713,061 people.
 In May 2017, the Asian Research and Training Institute for Skill Transfer (ARTIST) announced plans to
create around 1 million skilled healthcare providers by 2022.
Fifth Largest Employer
 Indian healthcare sector, one of the fastest growing industries, is expected to advance at a CAGR of 22.87
per cent during 2015–20 to reach US$ 280 billion by 2020. There is immense scope for enhancing
healthcare services penetration in India, thus presenting ample opportunity for development of the healthcare
industry
Impressive Growth
Prospects
 Rising income levels, ageing population, growing health awareness and changing attitude towards preventive
healthcare is expected to boost healthcare services demand in future
 The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients
from across the world. Moreover, India has emerged as a hub for R&D activities for international players due
to its relatively low cost of clinical research
Strong Fundamentals
and Cost Advantage
 Conducive policies for encouraging FDI, tax benefits, favourable government policies coupled with promising
growth prospects have helped the industry attract private equity, venture capitals and foreign players
Favourable Investment
Environment

ADVANTAGE INDIA
 Healthcare revenue in India is set to reach
US$ 280 billion by 2020; expenditure is
likely to expand at a CAGR of 17 per cent
over 2011–20
 Rising incomes, greater health awareness,
lifestyle diseases and increasing access to
insurance will contribute to growth
 Investment in healthcare infrastructure is
set to rise, benefiting both ‘hard’
(hospitals) and ‘soft’ (R&D, education)
infrastructure
 India is the largest exporter of formulations
with 14 per cent market share and ranks
12th in the world in terms of export value.
Double-digit growth is expected over the
next 5 years
 Availability of a large pool of well-trained
medical professionals in the country
 India has an advantage over its peers in
the West and Asia in terms of cost of high-
quality medical services offered
 The government aims to develop India as
a global healthcare hub
 Policy support in the form of reduced
excise and customs duty and exemption in
service tax
 Creation of new drug testing laboratories
and further strengthening of the 31
existing state laboratories
ADVANTAGE
INDIA
Source: KPMG, Deloitte, Hospital Market – India by Research on India, Frost and Sullivan, LSI Financial Services, ‘Report on Healthcare, Telemedicine and Medical Tourism in India’- ASA
and Associates LLP, Aranca Research
Note: RandD – Research and Development, CAGR - Compound Annual Growth Rate, US$ – US Dollar, F – Forecast, E - Estimate

HEALTHCARE
MARKET
OVERVIEW AND
TRENDS

Hospitals
Pharmaceutical
Diagnostics
Medical Equipment
and Supplies
Medical Insurance
Telemedicine
Private hospitals – It includes nursing homes and mid-tier and top-tier
private hospitals
Government hospitals – It includes healthcare centres, district hospitals and
general hospitals
It includes manufacturing, extraction, processing, purification and packaging
of chemical materials for use as medications for humans or animals
It comprises businesses and laboratories that offer analytical or diagnostic
services, including body fluid analysis
It includes establishments primarily manufacturing medical equipment and
supplies, e.g. surgical, dental, orthopaedic, ophthalmologic, laboratory
instruments, etc
It includes health insurance and medical reimbursement facility, covering an
individual’s hospitalisation expenses incurred due to sickness
Telemedicine has enormous potential in meeting the challenges of
healthcare delivery to rural and remote areas besides several other
applications in education, training and management in health sector
THE HEALTHCARE MARKET FUNCTIONS THROUGH
FIVE SEGMENTS
Source: Hospital Market – India by Research on India, Aranca Research
Healthcare

STRONG GROWTH IN HEALTHCARE EXPENDITURE
OVER THE YEARS
Source: Frost and Sullivan, LSI Financial Services, Deloitte, Aranca Research
45
51.7
59.5
68.4
72.8
81.3
104.0
110.0
160.0
280.0
0
50
100
150
200
250
300
2008 2009 2010 2011 2012 2014 2015 2016 2017F2020F
 Healthcare has become one of India's largest sectors both in terms
of revenue and employment. The industry is growing at a
tremendous pace owing to its strengthening coverage, services and
increasing expenditure by public as well private players
 During 2008-20, the market is expected to record a CAGR of 16.5
per cent
 The total industry size is expected to touch US$ 160 billion by 2017
and US$ 280 billion by 2020
 The Ministry of Health is focusing on development of technologies for
the treatment of diseases like Cancer and TB.
 Government is emphasising on the eHealth initiatives such as
Mother and Child Tracking System (MCTS) and Facilitation Centre
(MCTFC)
 Indian companies are entering into merger and acquisitions with
domestic and foreign companies to drive growth and gain new
markets.
Visakhapatnam port traffic (million tonnes)Healthcare Sector Growth Trend (US$ Billion)
CAGR: 16.5%
Note: F - Forecast

PRIVATE SECTOR HAS A STRONG PRESENCE IN
INDIA’S HEALTHCARE SECTOR
 The private sector has emerged as a vibrant force in India’s healthcare industry, lending it both national and international repute
 Large investments by private sector players are likely to contribute significantly to the development of India’s hospital industry, which comprises
around 80 per cent of the total market
 In India, private healthcare accounts for almost 74 per cent of the country’s total healthcare expenditure
 Private sector’s share in hospitals and hospital beds is estimated at 74 per cent and 40 per cent, respectively.
 The main factor contributing to rising medical tourism in India is presence of a well-educated, English-speaking medical staff in state-of-the art
private hospitals and diagnostic facilities
Shares in Healthcare Spending in India, 2015
19%
40%
11%
30%
Government hospital
Top tier
Mid tier
Nursing home
Shares in Healthcare Spending in India, 2005
34%
26%
14%
26%
Government hospital
Top tier
Mid tier
Nursing home

PER CAPITA HEALTHCARE EXPENDITURE HAS RISEN
AT A FAST PACE
54
61
58
61 61.9
68.6
0
10
20
30
40
50
60
70
80
2010 2011 2012 2013 2014 2015
 Per capita healthcare expenditure grew at a CAGR of 5 per cent
during 2008–15 to US$ 68.6.
 This is due to rising incomes, easier access to high-quality
healthcare facilities and greater awareness of personal health and
hygiene
 Greater penetration of health insurance aided the rise in healthcare
spending, a trend likely to intensify in the coming decade
 Economic prosperity is driving the improvement in affordability for
generic drugs in the market
Visakhapatnam port traffic (million tonnes)Per-capita healthcare expenditure (US$)
CAGR: 5%
Source: World Bank, BMI Report

NOTABLE TRENDS IN THE INDIAN HEALTHCARE
SECTOR … (1/2)
Source: IRDA, CII, Grant Thornton, Gartner, Technopak, Aranca Research
Note: PPP is Public – Private Partnerships, Management contracts - An arrangement under which operational control of an enterprise is given to a separate entity for a fee
 Telemedicine is a fast-emerging sector in India; major hospitals (Apollo, AIIMS, Narayana Hrudayalaya)
have adopted telemedicine services and entered into a number of PPPs
 As of FY16, telemedicine market in India was valued at US$ 15 million and is expected to rise at a CAGR of
20 per cent during FY16-20, reaching to US$ 32 million by 2020
 Telemedicine can bridge the rural-urban divide in terms of medical facilities, extending low-cost consultation
and diagnosis facilities to the remotest of areas via high-speed internet and telecommunication.
Emergence of
telemedicine
 Vaatsalya Healthcare is one of the first hospital chains to start focus on Tier 2 and Tier 3 for expansion
 To encourage the private sector to establish hospitals in these cities, the government has relaxed the taxes
on these hospitals for the first five years
Expansion to tier-II and
tier-III cities
 With increasing urbanisation and problems related to modern-day living in urban settings, currently, about 50
per cent of spending on in-patient beds is for lifestyle diseases; this has increased the demand for
specialised care. In India, lifestyle diseases have replaced traditional health problems.
 Most lifestyle diseases are caused by high cholesterol, high blood pressure, obesity, poor diet and alcohol
Shift from communicable
to lifestyle diseases
 Many healthcare players such as Fortis and Manipal Group are entering management contracts to provide
an additional revenue stream to hospitals
Management contracts

NOTABLE TRENDS IN THE INDIAN HEALTHCARE
SECTOR … (2/2)
Source: Business Standard, Ministry of External Affairs, Ministry of External Affairs (Investment and Technology Promotion Division)
 In FY18 (till June 2017), gross direct premium income from health insurance stood at 27.89 per cent of
overall gross direct premium income for non life insurance segment
 Health insurance is gaining momentum in India; witnessing growth at a CAGR of 23.6 per cent during FY15-
17. Gross healthcare insurance premium in the month of August this fiscal year stood at US$ 85.4 million
Increasing penetration of
health insurance
 A new trend is emerging as luxury offerings in healthcare sector. More than essential requirements,
healthcare providers are making offerings of luxurious services. For example: pick and drop services for
patient by private helicopters and luxurious arrangements for visitors to patient in hospital
Luxury offering
 Digital Health Knowledge Resources, Electronic Medical Record, Mobile Healthcare, Electronic Health
Record, Hospital Information System, PRACTO, Technology-enabled care, telemedicine and Hospital
Management Information Systems are some of the technologies gaining wide acceptance in the sector
 AIIMS to convert all its payment transaction cashless, for which it has associated with mobile wallet
company, MobiKwik, in January 2017.
Technological initiatives
 Strong mobile technology infrastructure and launch of 4G is expected to drive mobile health initiatives in the
country
 Cycle tel Humsafar is a SMS based mobile service designed for women, it enables women to plan their
family in a better way
 Mobile health industry in India is expected to reach US$ 0.6 billion by 2017
Mobile-based health
delivery

HEALTHCARE
PORTERS FIVE
FORCES ANALYSIS

Porter’s Five Force Framework Analysis
 Bargaining power of suppliers in this
industry is high because quality of
products and timely delivery matter
and there are less number of quality
suppliers
Bargaining Power of Suppliers
 Customers may go for public hospitals
which are inexpensive
 Customers might go for E-Health
Threat of Substitutes
 Increase in number of private players
in the market has led to increased
competition
 However number of hospitals is still
low compared to the requirement so
there is not much competition in the
market
Competitive Rivalry
 Big threat of new entrants in the
industry
 Number of players has increased
considerably in recent times
Threat of New Entrants
 Bargaining power of customers is low
because of trust and loyalty however
increase in number of options has
given customers some bargaining
power
Bargaining Power of Buyers
Positive Impact
Neutral Impact
Negative Impact
Source: Aranca Research

STRATEGIES ADOPTED
 In April 2017, IFFCO has invested 26 per cent stake in a start-up firm Gramin Health Care (GHC), a affordable and
easily accessible service for farmers to educate them about basic health.
 In April 2017, Religare sold its 80 per cent stake in Religare Health Insurance Co. Ltd. to a group of investors led by
True North for US$ 193.37 million.
 Serum Institute of India, the world's largest vaccine manufacturer, buys a defunct unit of Nanotherapeutics Inc., Czech
Republic-based injectable polio doses maker, for US$ 78.49 million. The acquisition will help the Serum Institute of India
to become the largest manufacturer of injectable polio vaccine in the world by increasing production capacityfour-fold to
more than 200 million doses by 2019.
 General Atlantic Partners and TPG voiced intentions to bid jointly for acquiring the healthcare assets of Fortis for US$
1.80 billion.
Merger and Acquisitions
 Private players in the industry are making their supply chains efficient and leveraging economies of scope to reduce
cost. One such example is Narayan Hrudayalaya (NH) where health care is provided at affordable cost. NH reduces
cost by:
• High procurement of medical supplies
• High-volume by high capacity utilisation and staff productivity
• Good human capital management (i.e. training)
Cost leadership
 Certain players in industry focus only on providing one kind of health care service to its customers. This also helps them
to be the leader in that service. Many examples can be quoted for hospitals focusing on treatment of cancer and
providing leading cancer treatment and eye related problems and treatments in India.
Focus
 Players in the industry are trying to differentiate themselves by providing multiple health care services under one roof. In
2015, many hospitals have collaborated with government to provide healthcare facilities in rural areas
 Offering a range of healthcare and wellness services under a single brand has become a trend. Patients and healthcare
services seekers find it convenient. Demand of such arrangements boosts the healthcare sector.
Differentiation and
diversified business
approach

INDIAN HEALTHCARE SECTOR IS POISED TO GROW
 Rising incomes and affordability
 Growing elderly population, changing disease patterns
 Rise in medical tourism
 Better awareness of wellness, preventive care and diagnosis
Growing Demand
 Rising FDI and private sector investments
 Lucrative M and A opportunities
 Foreign players setting R and D centres and hospitals
Merger and Acquisitions
 Encouraging policies for FDI and the private sector
 Reduction in customs duty and other taxes on life-saving equipment
 NRHM allocated US$ 10 billion for healthcare facilities
 National Health Insurance Mission to cover entire population
Policy Support
 Expanding research and development and distribution facilities in India
 Use of modern technology
 Providing support to global projects from India
Focus
Source: Health Ministry, Aranca Research
Note: FDI – Foreign Direct Investment, MandA - Mergers and Acquisitions NRHM - National Rural Health Mission

RISING INCOME, AGEING POPULATION TO BE KEY
HEALTHCARE DEMAND DRIVER
 Rising incomes mean a steady growth in the ability to access
healthcare and related services
 During 2015-19, per capita income is expected to increase at a
CAGR of 8.09 per cent
 Per capita expenditure on healthcare in India was US$ 68.6
 Moreover, changing demographics will also contribute to greater
healthcare spending; this is likely to continue with the size of the
elderly population set to rise from the current 98.9 million to about
168 million by 2026
Visakhapatnam port traffic (million tonnes)Trends in per capita income in India (USD)
985
1102
1228
1343
1462
1611
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
14.0%
0
200
400
600
800
1000
1200
1400
1600
1800
FY12
FY13
FY14
FY15
FY16
FY17
GDP per capita, current prices Growth Rate

LIFESTYLE DISEASES AND GROWING AWARENESS
TO INCREASE HOSPITALISATION
 The purported rise of lifestyle diseases in India is expected to boost
industry sales figures
 Increased incidences such as heart disease, obesity and diabetes
have contributed to rising healthcare spending by individuals
 Growing health awareness and precautionary treatments coupled
with improved diagnostics are resulting in an increase in
hospitalisation
 Indian system of healthcare, Ayurveda has unique therapies which
are beneficial for treatment of many chronic lifestyle disorders and
thus attracting more number of patients to avail these services in
India
 CAGR of hospitalised cases from 2008 – 18:
• Cardiac – 18 per cent
• Oncology – 16 per cent
• Diabetes – 19 per cent
Visakhapatnam port traffic (million tonnes)Number of hospitalised cases (million)
2.9
2
1.2
5.2
3.1
2.3
8.3
4.2
3.4
0
1
2
3
4
5
6
7
8
9
Cardiac Oncology Diabetes
2008 2013E 2018F
Source: Apollo Investor Presentation March 2016

MEDICAL TOURISM: A NEW GROWTH FACTOR FOR
INDIA’S HEALTHCARE SECTOR
 Presence of world-class hospitals and skilled medical professionals has strengthened India’s position as a preferred destination for medical
tourism
 Superior quality healthcare, coupled with low treatment costs in comparison to other countries, is benefiting Indian medical tourism which has, in
turn, enhanced the prospects of the Indian healthcare market
 Treatment for major surgeries in India costs approximately 20 per cent of that in developed countries
 India also attracts medical tourists from developing nations due to lack of advanced medical facilities in many of these countries
 As of April 2017, medical tourism market in India is US$ 3.0 billion in size and is expected to reach US$ 6 billion by 2018. During 2013-16, the
country’s medical tourism market witnessed growth at a CAGR of 27 per cent.
 The number of foreign tourists coming to India for medical purposes rose by almost 50 per cent to 201,333 in 2016 from 134,344 in 2015.
 Yoga, meditation, ayurveda, allopathy and other traditional methods of treatment are major service offerings that attract medical tourists from
European nations and the Middle East to India
Source: Ministry of Health, RNCOS, KPMG, Deloitte, Medical Tourism Association, LSI Financial Services, Apollo Investor Presentation, Aranca Research

RE-EMERGENCE OF TRADITIONAL MEDICAL CARE
Source: Ministry of Health, Make in India, RNCOS, KPMG, Aranca Research; Notes: AYUSH - Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy
 Many big players such as Apollo, VLCC and Manipal Group are also setting up wellness centres across
India, with traditional healthcare remedies as the focus of their offerings
 As of March 2017, Philips is shifting its focus towards adoption of new wave technologies for enhancing its
hold in healthcare sector by leveraging its expertise in Deep Learning, Machine Learning and Artificial
Intelligence.
Leading brands and
players
 The traditional medical sector is developing Traditional Knowledge Digital Library to prevent companies from
claiming patents on such remedies
 There is growing interest from numerous private equity firms in the traditional healthcare sector in India
 6,200 indigenous herbal plants
Notable trends
 The traditional (ayurvedic) market in India is expected to rise at a CAGR of 16 per cent over 2016-2021. In
2015, Government of India had approved All India Institute of Ayurveda in New Delhi, it would be a 200
bedded hospital. The institute was inaugurated in October 2017 on the occasion of Ayurveda Day.
 Ayurvedic medicines offer traditional Indian health remedies based on natural and herbal ingredients
 The sector has broadened its offerings and now includes services on diet and nutrition, yoga, herbal
medicine, humour therapy and spa
Market size and
Services Offered
 In Union Budget 2017-18, the government has decided to setup 2 new AIIMS in Jharkhand and Gujarat.
 As of December 2016, the country has a total of 403 Ayurveda, Siddha and Unani colleges and attached
hospitals.
 In Union Budget 2017-18, the plan outlay for AYUSH is estimated at US$ 212.5 million
 In September 2017, number of primary health centres (PHCs) increased to 32,224 and number of sub
centres reached to 166,643
Developing infrastructure

PRIVATE PLAYERS ARE KEY CONTRIBUTORS TO
GROWTH IN NUMBER OF HOSPITALS
 A major portion of secondary, tertiary and quaternary healthcare
institutions comes from private sector with a concentration in metros,
tier II and tier I cities.
 Large investments by private sector players are likely to contribute
significantly to the development of India's hospital industry and the
sector is poised to grow to US$ 100 billion by 2015 and further to
US$ 280 billion by 2020
 The private hospital market in India is estimated at US$ 81.0 billion
at the end-of 2015
 During 2009–15, the market size of private hospitals is estimated to
have a CAGR of 24.2 per cent
 Increase in number of hospitals in Tier-II and Tier-III cities has
fuelled the growth of private sector
Visakhapatnam port traffic (million tonnes)Market Size of Private Hospitals (US$ Billion)
22
29.9
35.4
45
54
81
0
10
20
30
40
50
60
70
80
90
2009 2010 2011 2012 2014 2015
Source: WHO Statistical Information System, Indian Chamber of Commerce, Yes Bank, Aranca Research

GROWING IN-PATIENT / OUT-PATIENT AND
DIAGNOSTIC MARKET
Market Size of In-patient/Out-patient Market Size of Diagnostic Market (US$ Billion)
 Over 2015-20, the In-Patient market is expected to grow at a
CAGR of 13 per cent
 Over 2015-20, the Out-Patient market is expected to grow at
CAGR of 10 per cent
 As of 2016, the inventory of all bio-medical equipment stood
around 7,56,750 worth US$ 697.21 million in 29,115 health
facilities of India
 Over 2012-22, diagnostic market is expected to grow at a CAGR
of 20.4 per cent to US$ 32 billion from US$ 5 billion in 2012
 Sub-sector of diagnostic, IVD Equipment market is expected to
grow at a CAGR of around 15 per cent from 2012 to 2015
 Diagnostic market is split between imaging and pathology with 30
per cent and 70 per cent share respectively
53%
81% 83%
47% 19% 17%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2015 2020F
In-Patient Out-Patient
5
6
7
12
32
0
5
10
15
20
25
30
35
2012 2013 2014 2015 2022E
CAGR: 20.4%

STRONG POLICY SUPPORT CRUCIAL IN DEVELOPING
THE SECTOR … (1/3)
 The benefit of section 10 (23 G) of the IT Act has been extended to financial institutions that provide long-term capital to
hospitals with 100 beds or more
 Government is encouraging the PPP model to improve availability of healthcare services and provide healthcare
financing.
 Till October 2015, 5 projects under PPP have been completed and has become operational
 Many reforms were introduced in the 2017-18 Union Budget, wherein the government announced that Aadhar based
smart-cards will be issued to senior citizens to monitor health. Moreover, the health sub centers, numbering to 1.5 lakh,
will be transformed into health wellness centers.
Encouraging the private
sector
 The benefit of section 80-IB has been extended to new hospitals with 100 beds or more that are set up in rural areas;
such hospitals are entitled to 100 per cent deduction on profits for 5 years
Encouraging investments
in rural areas
 In December 2016, Health Ministry undertook BMMP to avoid wastage of either unused medical equipment or used. The
programme will ensure the proper maintenance of medical equipment that are used in hospitals.
Biomedical Equipment
Management and
Maintenance Program
(BMMP)
 All healthcare education and training services are exempted from service tax
 Increase in tax holiday under section 80- IB for private healthcare providers in non metros for minimum of 50 bedded
hospitals
 250 per cent deduction for approved expenditure incurred on operating technology enables healthcare services such as
tele medicine , remote radiology
 Excise duty on chassis for ambulance reduced from 24 per cent to 12.5 per cent
 Artificial heart is exempted from basic custom duty of 5 per cent
 Income tax exemption for 15 years for domestically manufactured medical technology products
Tax incentives

 The Union Cabinet, Government of India, has approved the National Health Policy 2017, which will provide the policy
framework for achieving universal health coverage and delivering quality health care services to all at an affordable cost.
National Health Policy
2017
 Incentives and tax holidays are being offered to hospitals and dispensaries providing health travel facilities. Senior
citizens above 80 years of age will be allowed deduction of US$ 491 towards medical expenditure if they are not
covered under health insurance
Incentives in the medical
travel industry
 In Union Budget 2017-18, Government has allocated US$ 7.8 billion to Ministry of Health and Family Welfare. Also,
1,50,000 Heath Sub centres will be transformed into Health and Wellness Centres in 2017-18, according to Budget
2017-18.
 Also, an amount of US$ 38.45 million was allocated to Department of Pharmaceuticals.
 As per Union Budget 2017-18, National Health Mission was allocated US$ 4.21 billion.
 3,000 medical stores are to be set up across the country with an aim to provide quality medicines at cost effective prices
Fund allocation by
government
 Creation of new drug testing laboratories and further strengthening of the 31 existing state laboratoriesLaboratories

 To set up a health infrastructure fund and make an access, a fund for health care has been allocated under
the Union budget for infrastructure and innovation specially for the Tier 2, Tier 3 and rural areas
 To raise the tax exemption level on the preventive health check-up to US$ 297.48 from current existing
amount of US$ 74.37, which will be exempted under the section 80D of the Income Tax Act, to achieve the
universal healthcare coverage
 To increase the deduction towards medical insurance premium, the current deduction limit being US$ 223.11
which is to be increased to US$ 743.71 for self and for family. In the case of dependent parents the current
limit of US$ 297.48 needs to be increased to US$ 743.71. The GST exemption should cover health
insurance premium
 Under the Union Budget 2017, there is a provision for increasing the depreciation rate on the medical
devices and equipment from 15 per cent to 30 per cent
 To get the tax benefit, on the limit of annual medical reimbursement is to be raised from US$ 223.11 each to
at least US$ 1487.43 each per house
 The import tariffs/duties which are levied on the health care (drugs, surgical equipment), the same is to be
completely removed if its manufactured in India
Union Budget 2017-18
 In October 2017, All India Institute of Ayurveda was inaugurated in New Delhi. The institute has been set up
over an area of 10 acres at a cost of US$ 24.37 million.
 As a part of increasing healthcare infrastructure in India, the government announced setting up of 2 new
AIIMS in Jharkhand and Gujarat.
Medical institutions

SUPPORTIVE POLICIES DRIVE FDI INFLOWS
 100 per cent FDI is allowed under the automatic route for greenfield
projects
 For brownfield project investments, up to 100 per cent FDI is
permitted under the government route
 Demand growth, cost advantages and policy support have been
instrumental in attracting FDI
 During April 2000 – June 2017, FDI inflows for drugs and
pharmaceuticals sector stood at US$ 14.99 billion.
 Inflows into sectors such as hospitals and diagnostic centers and
medical appliances stood at US$ 4.58 billion and US$ 1.61 billion,
respectively, during the same period
 In February 2017, German healthcare firm Merck announced its
plans to open their 4th bio production centre worldwide and their 1st
in India. It will help the local companies to manufacture biosimilars
and biotech drugs.
Visakhapatnam port traffic (million tonnes)
Cumulative FDI inflows (From April 2000 Up to June 2017) into
the healthcare sector (US$ million)
4.38%
1.34%
0.47%
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%
3.50%
4.00%
4.50%
5.00%
0
2000
4000
6000
8000
10000
12000
14000
16000
Drug and
Pharmaceuticals
Hospital and
Diagnostic
Centers
Medical and
Surgical
Appliances
Cumulative FDI inflows (US$ million)
Share of the Total FDI inflows
Source: Department of Industrial Policy and Promotion, Aranca Research
Note: FDI – Foreign Direct Investment

OPPORTUNITIES IN HEALTHCARE
 Additional 3 million beds needed for India to achieve the target of 3 beds per 1,000 people
by 2025
 Additional 1.54 million doctors and 2.4 million nurses required to meet the growing demand for healthcare
 Over US$ 200 billion is expected to be spent on medical infrastructure by 2024
 Over the years, India has made strategic interventions in National Health Mission and the national disease
control programmes to ensure quality and affordable healthcare for all.
Healthcare Infrastructure
 Contract research is a fast growing segment in the Indian healthcare industry
 Cost of developing new drugs is as low as 60 per cent of the testing cost in the US
 About 60 per cent of global clinical trials is outsourced to developing countries
 The Contract Research and Manufacturing Services industry (CRAMS) is estimated at US$ 8 billion in 2015,
up from US$ 3.8 billion in 2012. The market has more than 1000 players
Research
 The Indian medical tourism industry is expected to reach US$ 6 billion by 2018 from US$ 3.0 billion in April
2017, growing at a CAGR of 27 per cent over 2013-16
 The number of foreign tourists coming to India for medical purposes rose by almost 50 per cent to 201,333 in
2016 from 134,344 in 2015.
 Cost of surgery in India is nearly one-tenth of the cost in developed countries
 There are 21 Joint Commission International (JCI) - accredited hospitals in India and growing
Medical Tourism

SCOPE FOR GROWTH, AS HEALTHCARE SERVICES
REMAIN UNDER-REPRESENTED
Healthcare Spending as a Percentage of GDP between 2015-19 Huge scope for enhancing healthcare services considering that
healthcare spending as a percentage of GDP
 Rural India, which accounts for over 70 per cent of population and is
set to emerge as a potential demand source
 Only 3 per cent of specialist physicians cater to rural demand
 Vast opportunities for investment in healthcare infrastructure in both
urban and rural India
10.6%
4.1%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
World India
Source: WHO World Health Statistics 2015, EandY, LSI Financial Services, Fortis Investor Presentation, Aranca Research
(1): 1 bed for every 1050 patients
Health Infrastructure per 1000 Individual (2013- 2015)
Physicians
Nurses and midwifery
personnel
Hospital beds
India 0.7 1.5 1(1)
World median 2.5 2.5 2.9

OPPORTUNITIES IN HEALTH INSURANCE
Health Insurance Premium Collection (US$ Billion) As of 2016, less than 15 per cent of the Indian population is covered
through health insurance
 Increasing healthcare cost and burden of new diseases along with
low government funding is raising demand for health insurance
coverage
 Many companies offer health insurance coverage to employees,
driving market penetration of insurance players
 By 2015, spending through health insurance will reach 8.4 per cent
of total health spending, up from 6.4 per cent in 2009–10
 The share of population having medical insurance is likely to rise to
20 per cent by 2015
 With increasing demand for affordable and quality healthcare,
penetration of health insurance is poised to grow exponentially in the
coming years
 In 2016-17, the overall health insurance premium collected in India
was recorded at US$ 4.78 billion.
 Health insurance premiums increased at a CAGR of 21.15 per cent
between 2008–09 and 2016-17.
1.03 1.3
2.42
2.79 2.85 2.9
3.6
4.08
4.78
0
1
2
3
4
5
6
2008-09
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
2016-17
CAGR: 21.15%

MAX HEALTHCARE: WELL POISED TO TAP GROWTH
OPPORTUNITIES
Source: Aranca Research, Company Website
 Max Medcentre, Panchsheel Park – First Medcenter with OP
facilities and day care surgeries
 Max Hospital, Pitampura – First hospital to be ISO certified
and first high end secondary care centre in North Delhi.
 Max Heart and Vascular Institute, Saket - First Super
Tertiary Care Facility with Advanced Cardiac Life Support
Ambulances and Air Evacuation Service.
 Max Super Speciality Hospital, Bathinda- Max
Healthcare extended its footprint in North India
 Max Super Speciality Hospital, Dehradun, Max
Healthcare opened its first Super Speciality hospital
in Uttarakhand
 Max Multi Speciality Hospital, Greater Noida -
 Pushpanjali Crosslay Hospital officially
becomes Max Super Speciality
Hospital
 Saket City Hospital officially becomes
Max Smart Super Speciality Hospital
 Max Super Speciality Hospital, Saket
is accredidated by the Joint
Commission International
 Max Super Speciality Hospital, Saket - First Multi, Super
Speciality Tertiary Care Location
 Max Hospital, Gurgaon - High End Secondary Care Centre in
Gurgaon
 Max Healthcare received NABH and NABL certification for its
laboratories.
 Max Healthcare receives NABH Accreditation for Blood bank
 The company was founded and
listed in the NSE and BSE with
37,000 shareholders.
1985
2015
onwards
2011-142006-102000-05

GLOBAL HOSPITALS: SET TO GROW WITH HOSPITAL
NETWORK EXPANSION
Source: Aranca Research, Annual Report
 Global Health City received
NABH accreditation
 3,00,000 In Patients and 50,000
Out Patients annually
 Current capacity of about 2,000
beds
 As of March 2017, the company is
planning to invest US$ 310 million
for expansion.
 Commission of Global Hospitals,
Mumbai with 450 – bed multi –
super speciality and multi – organ
transplant facility
 First hospital opened
in Hyderabad
1998 2015
onwards
20122010
First hospital to carry out
intravascular surgery
First hospital to perform
radial procedures
First hospital to be recognised
for RandD by Govt. of India
Leading multi-organ
transplant centre
Completed highest radial
Procedures in India
Third Hospital to attract
huge funds

HEALTHCARE
KEY INDUSTRY
ORGANISATIONS

INDUSTRY ORGANISATIONS
I.M.A. House
Indraprastha Marg,
New Delhi – 110 002, India
Telephone: 91 11 2337 0009, 2337 8819
Fax: 91 11 2337 9470, 2337 9178
Website: www.ima-india.org
E-mail: inmedici@vsnl.com
Indian Medical Association
Model Residency, 605,
Bapurao Jagtap Marg,
Jacob Circle, Mahalaxmi East,
Mumbai – 400 011, India
Fax: 23021383
Website: www.fogsi.org
E-mail: inmedici@vsnl.com
The Federation of Obstetric and Gynaecological Societies of
India

GLOSSARY
 CAGR: Compound Annual Growth Rate
 EPA: Externally Aided Projects
 FDI: Foreign Direct Investment
 FY: Indian Financial Year (April to March)
 So FY10 implies April 2009 to March 2010
 GOI: Government of India
 ICT: Information and Communications Technology
 IMF: International Monetary Fund
 INR: Indian Rupee
 MandA: Mergers and Acquisitions
 NHRM: National Rural Health Mission
 PPP: Public Private Partnerships
 RandD: Research and Development
 US$: US dollar
 WHO: World Health Statistics
 Where applicable, numbers have been rounded off to the nearest whole number

EXCHANGE RATES
Year INR Equivalent of one US$
2004–05 44.81
2005–06 44.14
2006–07 45.14
2007–08 40.27
2008–09 46.14
2009–10 47.42
2010–11 45.62
2011–12 46.88
2012–13 54.31
2013–14 60.28
2014-15 61.06
2015-16 65.46
2016-17 67.09
Q1 2017-18 64.46
Year INR Equivalent of one US$
2005 43.98
2006 45.18
2007 41.34
2008 43.62
2009 48.42
2010 45.72
2011 46.85
2012 53.46
2013 58.44
2014 61.03
2015 64.15
2016 67.21
H1 2017 65.73
Exchange Rates (Fiscal Year) Exchange Rates (Calendar Year)
Source: Reserve bank of India, Average for the year

DISCLAIMER
India Brand Equity Foundation (IBEF) engaged Aranca to prepare this presentation and the same has been prepared by Aranca in consultation
with IBEF.
All rights reserved. All copyright in this presentation and related works is solely and exclusively owned by IBEF. The same may not be reproduced,
wholly or in part in any material form (including photocopying or storing it in any medium by electronic means and whether or not transiently or
incidentally to some other use of this presentation), modified or in any manner communicated to any third party except with the written approval
of IBEF.
This presentation is for information purposes only. While due care has been taken during the compilation of this presentation to ensure that the
information is accurate to the best of Aranca and IBEF’s knowledge and belief, the content is not to be construed in any manner whatsoever as a
substitute for professional advice.
Aranca and IBEF neither recommend nor endorse any specific products or services that may have been mentioned in this presentation and nor do
they assume any liability or responsibility for the outcome of decisions taken as a result of any reliance placed on this presentation.
Neither Aranca nor IBEF shall be liable for any direct or indirect damages that may arise due to any act or omission on the part of the user due to any
reliance placed or guidance taken from any portion of this presentation.

Healthcare Sector Report October 2017

More Related Content

What's hot (20)

Similar to Healthcare Sector Report October 2017 (20)

More from India Brand Equity Foundation (20)

Recently uploaded (20)

Healthcare Sector Report October 2017